Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
Add more filters










Publication year range
1.
Sci Transl Med ; 5(188): 188le2, 2013 Jun 05.
Article in English | MEDLINE | ID: mdl-23740897

ABSTRACT

Egawa et al. recently showed the value of patient-specific induced pluripotent stem cells (iPSCs) for modeling amyotrophic lateral sclerosis in vitro. Their study and our work highlight the need for complementary assays to detect small, but potentially important, phenotypic differences between control iPSC lines and those carrying disease mutations.


Subject(s)
Amyotrophic Lateral Sclerosis/pathology , Drug Evaluation, Preclinical/methods , Induced Pluripotent Stem Cells/cytology , Motor Neurons/cytology , Humans
2.
Proc Natl Acad Sci U S A ; 109(15): 5803-8, 2012 Apr 10.
Article in English | MEDLINE | ID: mdl-22451909

ABSTRACT

Transactive response DNA-binding (TDP-43) protein is the dominant disease protein in amyotrophic lateral sclerosis (ALS) and a subgroup of frontotemporal lobar degeneration (FTLD-TDP). Identification of mutations in the gene encoding TDP-43 (TARDBP) in familial ALS confirms a mechanistic link between misaccumulation of TDP-43 and neurodegeneration and provides an opportunity to study TDP-43 proteinopathies in human neurons generated from patient fibroblasts by using induced pluripotent stem cells (iPSCs). Here, we report the generation of iPSCs that carry the TDP-43 M337V mutation and their differentiation into neurons and functional motor neurons. Mutant neurons had elevated levels of soluble and detergent-resistant TDP-43 protein, decreased survival in longitudinal studies, and increased vulnerability to antagonism of the PI3K pathway. We conclude that expression of physiological levels of TDP-43 in human neurons is sufficient to reveal a mutation-specific cell-autonomous phenotype and strongly supports this approach for the study of disease mechanisms and for drug screening.


Subject(s)
Induced Pluripotent Stem Cells/metabolism , Motor Neurons/pathology , Mutation/genetics , TDP-43 Proteinopathies/genetics , Adult , Cell Differentiation/drug effects , DNA-Binding Proteins/metabolism , Detergents/pharmacology , Female , Fibroblasts/drug effects , Fibroblasts/metabolism , Fibroblasts/pathology , Humans , Induced Pluripotent Stem Cells/drug effects , Male , Middle Aged , Motor Neurons/drug effects , Motor Neurons/metabolism , Organ Specificity/drug effects , Solubility/drug effects
3.
Cell Res ; 21(9): 1332-42, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21747414

ABSTRACT

Methylation of cytosine is a DNA modification associated with gene repression. Recently, a novel cytosine modification, 5-hydroxymethylcytosine (5-hmC) has been discovered. Here we examine 5-hmC distribution during mammalian development and in cellular systems, and show that the developmental dynamics of 5-hmC are different from those of 5-methylcytosine (5-mC); in particular 5-hmC is enriched in embryonic contexts compared to adult tissues. A detectable 5-hmC signal appears in pre-implantation development starting at the zygote stage, where the paternal genome is subjected to a genome-wide hydroxylation of 5-mC, which precisely coincides with the loss of the 5-mC signal in the paternal pronucleus. Levels of 5-hmC are high in cells of the inner cell mass in blastocysts, and the modification colocalises with nestin-expressing cell populations in mouse post-implantation embryos. Compared to other adult mammalian organs, 5-hmC is strongly enriched in bone marrow and brain, wherein high 5-hmC content is a feature of both neuronal progenitors and post-mitotic neurons. We show that high levels of 5-hmC are not only present in mouse and human embryonic stem cells (ESCs) and lost during differentiation, as has been reported previously, but also reappear during the generation of induced pluripotent stem cells; thus 5-hmC enrichment correlates with a pluripotent cell state. Our findings suggest that apart from the cells of neuronal lineages, high levels of genomic 5-hmC are an epigenetic feature of embryonic cell populations and cellular pluri- and multi-lineage potency. To our knowledge, 5-hmC represents the first epigenetic modification of DNA discovered whose enrichment is so cell-type specific.


Subject(s)
Cell Lineage , Cytosine/analogs & derivatives , Embryonic Development , Genome, Human , 5-Methylcytosine/analysis , 5-Methylcytosine/immunology , Animals , Antibodies/immunology , Bone Marrow/metabolism , Cell Differentiation , Cells, Cultured , CpG Islands , Cytosine/analysis , Cytosine/immunology , Cytosine/metabolism , DNA Methylation , Embryonic Stem Cells/cytology , Embryonic Stem Cells/metabolism , Humans , Induced Pluripotent Stem Cells/cytology , Induced Pluripotent Stem Cells/metabolism , Intermediate Filament Proteins/metabolism , Mice , Nerve Tissue Proteins/metabolism , Nestin , Neurons/metabolism , Zygote/growth & development
4.
Stem Cell Res ; 6(2): 92-102, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21277274

ABSTRACT

Maintaining stable differentiated somatic cell function in culture is essential to a range of biological endeavors. However, current technologies, employing, for example, primary hepatic cell culture (essential to the development of a bio-artificial liver and improved drug and toxicology testing), are limited by supply, expense, and functional instability even on biological cell culture substrata. As such, novel biologically active substrates manufacturable to GMP standards have the potential to improve cell culture-based assay applications. Currently hepatic endoderm (HE) generated from pluripotent stem cells is a genotypically diverse, cheap, and stable source of "hepatocytes"; however, HE routine applications are limited due to phenotypic instability in culture. Therefore a manufacturable subcellular matrix capable of supporting long-term differentiated cell function would represent a step forward in developing scalable and phenotypically stable hESC-derived hepatocytes. Adopting an unbiased approach we screened polymer microarrays and identified a polyurethane matrix which promoted HE viability, hepatocellular gene expression, drug-inducible metabolism, and function. Moreover, the polyurethane supported, when coated on a clinically approved bio-artificial liver matrix, long-term hepatocyte function and growth. In conclusion, our data suggest that an unbiased screening approach can identify cell culture substrate(s) that enhance the phenotypic stability of primary and stem cell-derived cell resources.


Subject(s)
Cell Culture Techniques , Hepatocytes/cytology , Hepatocytes/metabolism , Inactivation, Metabolic , Small Molecule Libraries , Animals , Cell Culture Techniques/instrumentation , Cell Culture Techniques/methods , Cell Differentiation , Cells, Cultured , Culture Media, Conditioned , Embryonic Stem Cells/cytology , Embryonic Stem Cells/physiology , Extracellular Matrix/chemistry , Humans , Liver, Artificial , Mice , Microarray Analysis , Molecular Structure , Pharmaceutical Preparations , Polymers/chemistry
5.
Cell Reprogram ; 12(2): 133-40, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20677928

ABSTRACT

Human embryonic stem cells (hESCs) offer an inexhaustible supply of human somatic cell types through their ability to self-renew while retaining pluripotency. As such, hESC-derived cell types are important for applications ranging from in vitro modeling to therapeutic use. However, for their full potential to be realized, both the growth of the undifferentiated cells and their derivatives must be performed in defined culture conditions. Many research groups maintain hESCs using mouse embryonic fibroblasts (MEF) and MEF conditioned medium (CM). The use of murine systems to support hESCs has been imperative in developing hESC technology; however, they suffer from some major limitations including lack of definition, xenobiotic nature, batch-to-batch variation, and labor-intensive production. Therefore, hESC culture definition is essential if hESC lines, and their derivatives are to be quality assured and manufactured to GMP. We have initiated the process of standardizing hESC tissue culture and have employed two serum-free media: mTeSR (MT) and Stem Pro (SP). hESCs were maintained in a pluripotent state, for over 30 passages using MT and SP. Additionally, we present evidence that hESCs maintained in MT and SP generate equivalent levels of human hepatic endoderm as observed with CM. This data suggests that MT and SP are effective replacements for MEF-CM in hESC culture, contributing to the standardization of hESC in vitro models and ultimately their application.


Subject(s)
Cell Culture Techniques , Culture Media, Conditioned/pharmacology , Culture Media, Serum-Free/pharmacology , Embryonic Stem Cells/cytology , Animals , Cell Differentiation , Cell Separation , Cells, Cultured , Cytochrome P-450 Enzyme System/chemistry , Flow Cytometry , Genetic Techniques , Humans , Mice , Pluripotent Stem Cells/cytology , Xenobiotics/pharmacology
6.
Hepatology ; 51(1): 329-35, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19877180

ABSTRACT

UNLABELLED: With the advent of induced pluripotent stem cell (iPSC) technology, it is now feasible to generate iPSCs with a defined genotype or disease state. When coupled with direct differentiation to a defined lineage, such as hepatic endoderm (HE), iPSCs would revolutionize the way we study human liver biology and generate efficient "off the shelf" models of human liver disease. Here, we show the "proof of concept" that iPSC lines representing both male and female sexes and two ethnic origins can be differentiated to HE at efficiencies of between 70%-90%, using a method mimicking physiological relevant condition. The iPSC-derived HE exhibited hepatic morphology and expressed the hepatic markers albumin and E-cadherin, as assessed by immunohistochemistry. They also expressed alpha-fetoprotein, hepatocyte nuclear factor-4a, and a metabolic marker, cytochrome P450 7A1 (Cyp7A1), demonstrating a definitive endodermal lineage differentiation. Furthermore, iPSC-derived hepatocytes produced and secreted the plasma proteins, fibrinogen, fibronectin, transthyretin, and alpha-fetoprotein, an essential feature for functional HE. Additionally iPSC-derived HE supported both CYP1A2 and CYP3A4 metabolism, which is essential for drug and toxicology testing. CONCLUSION: This work is first to demonstrate the efficient generation of hepatic endodermal lineage from human iPSCs that exhibits key attributes of hepatocytes, and the potential application of iPSC-derived HE in studying human liver biology. In particular, iPSCs from individuals representing highly polymorphic variants in metabolic genes and different ethnic groups will provide pharmaceutical development and toxicology studies a unique opportunity to revolutionize predictive drug toxicology assays and allow the creation of in vitro hepatic disease models.


Subject(s)
Cell Culture Techniques/methods , Cell Differentiation/physiology , Endoderm/cytology , Induced Pluripotent Stem Cells/cytology , Liver/cytology , Cell Lineage , Female , Humans , Male
7.
Proc Natl Acad Sci U S A ; 105(34): 12301-6, 2008 Aug 26.
Article in English | MEDLINE | ID: mdl-18719101

ABSTRACT

Human embryonic stem cells (hESCs) are a valuable source of pluripotential primary cells. To date, however, their homogeneous cellular differentiation to specific cell types in vitro has proven difficult. Wnt signaling has been shown to play important roles in coordinating development, and we demonstrate that Wnt3a is differentially expressed at critical stages of human liver development in vivo. The essential role of Wnt3a in hepatocyte differentiation from hESCs is paralleled by our in vitro model, demonstrating the importance of a physiologic approach to cellular differentiation. Our studies provide compelling evidence that Wnt3a signaling is important for coordinated hepatocellular function in vitro and in vivo. In addition, we demonstrate that Wnt3a facilitates clonal plating of hESCs exhibiting functional hepatic differentiation. These studies represent an important step toward the use of hESC-derived hepatocytes in high-throughput metabolic analysis of human liver function.


Subject(s)
Activins/physiology , Cell Differentiation , Embryonic Stem Cells/cytology , Endoderm/cytology , Liver/growth & development , Wnt Proteins/physiology , Animals , Gene Expression Regulation, Developmental , Hepatocytes/transplantation , Humans , Liver/cytology , Mice , Mice, SCID , Spleen/cytology , Transplantation, Heterologous , Wnt Proteins/genetics , Wnt3 Protein , Wnt3A Protein
8.
Cloning Stem Cells ; 10(3): 331-9, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18479212

ABSTRACT

Pluripotent stem cells are derived from the inner cell mass of preimplantation embryos, and display the ability of the embryonic founder cells by forming all three germ lineages in vitro. It is well established that the cellular niche plays an important role in stem cell maintenance and differentiation. Stem cells generally have limited function without the specialized microenvironment of the niche that provides key cell-cell contact, soluble mediators, and extracellular matrices. We were interested in the role that Wnt signaling, in particular Wnt3a, played in human embryonic stem cell (hESC) differentiation to hepatic endoderm in vitro. hESC differentiation to hepatic endoderm was efficient in pure stem cell populations. However, in younger hESC lines, generating stromal cell mesenchyme, our model was very inefficient. The negative effect of stroma could be reversed by pretreating hESCs with Wnt3a prior to the onset of hepatocyte differentiation. Wnt3a pretreatment reinstated efficient hESC differentiation to hepatic endoderm. These studies represent an important step in understanding hepatocyte differentiation from hESCs and the role played by the cellular niche in vitro.


Subject(s)
Cell Differentiation/physiology , Embryonic Stem Cells/physiology , Hepatocytes/physiology , Mesoderm/physiology , Stromal Cells/physiology , Wnt Proteins/metabolism , Cells, Cultured , Embryonic Stem Cells/cytology , Hepatocytes/cytology , Humans , Mesoderm/cytology , Stromal Cells/cytology , Wnt Proteins/genetics , Wnt3 Protein , Wnt3A Protein
9.
Cloning Stem Cells ; 10(1): 89-106, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18241127

ABSTRACT

Human embryonic stem cells (hESCs) are thought to be susceptible to chromosomal rearrangements as a consequence of single cell dissociation. Compared in this study are two methods of dissociation that do not generate single cell suspensions (collagenase and EDTA) with an enzymatic procedure using trypsin combined with the calcium-specific chelator EGTA (TEG), that does generate a single cell suspension, over 10 passages. Cells passaged by single cell dissociation using TEG retained a normal karyotype. However, cells passaged using EDTA, without trypsin, acquired an isochromosome p7 in three replicates of one experiment. In all of the TEG, collagenase and EDTA-treated cultures, cells retained consistent telomere length and potentiality, demonstrating that single cell dissociation can be used to maintain karyotypically and phenotypically normal hESCs. However, competitive genomic hybridization revealed that subkaryotypic deletions and amplifications could accumulate over time, reinforcing that present culture regimes remain suboptimal. In all cultures the cell surface marker CD30, reportedly expressed on embryonal carcinoma but not karyoptically normal ESCs, was expressed on hESCs with both normal and abnormal karyotype, but was upregulated on the latter.


Subject(s)
Cell Proliferation/drug effects , Collagenases/pharmacology , Embryonic Stem Cells/drug effects , Genome, Human/drug effects , Ki-1 Antigen/metabolism , Cell Culture Techniques , Cell Differentiation , Cells, Cultured , Chromosome Banding , Egtazic Acid/pharmacology , Embryonic Stem Cells/metabolism , Embryonic Stem Cells/physiology , Humans , K562 Cells , Karyotyping , Models, Biological , Trypsin/pharmacology
10.
Stem Cells ; 26(4): 894-902, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18238852

ABSTRACT

The potential to differentiate human embryonic stem cells (hESCs) in vitro to provide an unlimited source of human hepatocytes for use in biomedical research, drug discovery, and the treatment of liver diseases holds great promise. Here we describe a three-stage process for the efficient and reproducible differentiation of hESCs to hepatocytes by priming hESCs towards definitive endoderm with activin A and sodium butyrate prior to further differentiation to hepatocytes with dimethyl sulfoxide, followed by maturation with hepatocyte growth factor and oncostatin M. We have demonstrated that differentiation of hESCs in this process recapitulates liver development in vivo: following initial differentiation, hESCs transiently express characteristic markers of the primitive streak mesendoderm before turning to the markers of the definitive endoderm; with further differentiation, expression of hepatocyte progenitor cell markers and mature hepatocyte markers emerged sequentially. Furthermore, we have provided evidence that the hESC-derived hepatocytes are able to carry out a range of hepatocyte functions: storage of glycogen, and generation and secretion of plasma proteins. More importantly, the hESC-derived hepatocytes express several members of cytochrome P450 isozymes, and these P450 isozymes are capable of converting the substrates to metabolites and respond to the chemical stimulation. Our results have provided evidence that hESCs can be differentiated efficiently in vitro to functional hepatocytes, which may be useful as an in vitro system for toxicity screening in drug discovery.


Subject(s)
Cell Differentiation/physiology , Embryonic Stem Cells/cytology , Hepatocytes/cytology , Liver/cytology , Liver/growth & development , Animals , Biomarkers/metabolism , Cell Culture Techniques/methods , Cells, Cultured , Embryonic Stem Cells/physiology , Hepatocytes/physiology , Humans , Mice , Organogenesis/physiology
11.
Cloning Stem Cells ; 8(4): 319-34, 2006.
Article in English | MEDLINE | ID: mdl-17196096

ABSTRACT

The evolution of "humanized" (i.e., free of animal sourced reagents) and ultimately chemically defined culture systems for human embryo stem cell (hESC) isolation and culture is of importance to improving their efficacy and safety in research and therapeutic applications. This can be achieved by integration of a multitude of individual approaches to replace or eliminate specific animal sourced reagents into a single comprehensive protocol. In the present study our objective was to integrate strategies obviating reliance on some of the most poorly defined and path-critical factors associated with hESC derivation, namely the use of animal immune compliment to isolate embryo inner cell mass, and animal sourced serum products and feeder cells to sustain hESC growth and attachment. As a result we report the derivation of six new hESC lines isolated by outgrowth from whole blastocysts on an extracellular matrix substrate of purified human laminin (Ln) with transitional reliance on mitotically inactivated human fibroblast (HDF) feeder cells. With this integrated system hESC lines were isolated using either HDF conditioned medium supplemented with a bovine-sourced serum replacement (bSRM), or a defined serum-free medium (SFM) containing only human sourced and recombinant protein. Further, outgrowth of embryonic cells from whole blastocysts in both media could be achieved for up to 1 week without reliance on feeder cells. All variant conditions sustained undifferentiated cell status, a stable karyotype and the potential to form cells representative of all three germinal lineages in vitro and in vivo, when transitioned off of feeders onto Laminin or Matrigel. Our study thus demonstrates the capacity to integrate derivation strategies eliminating a requirement for animal immune compliment and serum products, with a transitional requirement for human feeder cells. This represents another sequential step in the generation of therapeutic grade stem cells with reduced risk of zoonotic pathogen transmission.


Subject(s)
Cell Culture Techniques , Cell Line , Embryonic Stem Cells , Animals , Blastocyst/cytology , Cell Proliferation , Cell Separation , Culture Media , Culture Media, Conditioned , Culture Media, Serum-Free , Fibroblasts/metabolism , Humans , Karyotyping , Laminin/metabolism , Mice
12.
Mol Reprod Dev ; 66(2): 126-33, 2003 Oct.
Article in English | MEDLINE | ID: mdl-12950099

ABSTRACT

Mice have been successfully cloned from somatic and embryonic stem (ES) cells using the "Honolulu method." In the present study, different donor oocytes and different culture conditions were compared to evaluate the developmental potential of nuclear transfer embryos reconstructed with an inbred ES cell line HM-1. Oocytes were recovered from two different F1 donors B6D2F1 (C57BL/6 x DBA/2) and B6CBAF1 (C57BL/6 x CBA). There was no effect of oocyte origin on development of cloned embryos to the morulae/blastocyst stage (B6D2F1 44.1% vs. B6CBAF1 45.0%), and the transferred embryos could develop to term. Two culture conditions were compared to show their ability to support development to the morulae/blastocyst stage of reconstructed embryos with B6D2F1 oocytes. The total cell number in the cloned blastocysts cultured in M16 with 20% oxygen was much higher than that observed in CZB with 20% oxygen. Low oxygen concentration during culture of nuclear transfer embryos in CZB medium showed no beneficial effect on pre-implantation development, no embryos developed to term after transfer to surrogate mothers. Our results demonstrated that not only B6D2F1, but B6CBAF1 oocytes, can be used for nuclear transfer. M16 medium is superior for culture of nuclear transfer embryos and low oxygen concentration with CZB medium during culture shows no benefit on development of cloned embryos.


Subject(s)
Cloning, Organism , Culture Media , Embryo, Mammalian/physiology , Embryonic and Fetal Development , Oocytes/physiology , Stem Cells/physiology , Animals , Blastocyst/cytology , Blastocyst/physiology , Cell Line , Cells, Cultured , Culture Techniques , Embryo Transfer/veterinary , Female , Male , Mice , Mice, Inbred C57BL , Mice, Inbred CBA , Mice, Inbred DBA , Nuclear Transfer Techniques , Oocytes/cytology , Pregnancy , Stem Cells/chemistry , Zygote/cytology , Zygote/growth & development
13.
Biol Reprod ; 68(2): 595-603, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12533424

ABSTRACT

Mice have been successfully cloned from both somatic cells and hybrid embryonic stem (ES) cells. Heterozygosity of the donor ES cell genome has been suggested as a crucial factor for long-term survival of cloned mice. In the present study, an inbred ES cell line, HM-1 (129/Ola), and a well-tested ES cell line, R1 (129/Sv x 129/Sv-CP), were used as donor cells to evaluate the developmental potential of nuclear transfer embryos. We found that ES cell confluence dramatically affects the developmental potential of reconstructed embryos. With the ES cell line HM-1 and 80-90% confluence, 49% of reconstructed embryos developed to the morula/blastocyst stage, 9% of these embryos developed to live pups when transferred to the surrogate mothers, and 5 of 18 live pups survived to adulthood. By contrast, at 60-70% confluence, only 22% of embryos developed to the morula/blastocyst stage, and after transfer, only a single fetus reached term. Consistent with previous reports, the nuclei of R1 ES cells were also shown to direct development to term, but no live pups were derived from cells at later passages (>20). Our results show that the developmental potential of reconstructed embryos is determined by both cell confluence and cell passage. These results also demonstrate that the inbred ES cell line, HM-1, can be used to produce viable cloned mice, although less efficiently than most heterozygous ES cell lines.


Subject(s)
Cloning, Organism/methods , Embryo, Mammalian/cytology , Stem Cells , Animals , Cell Cycle , Cell Line , Cytoskeleton/ultrastructure , DNA/physiology , Embryonic and Fetal Development , Female , Heterozygote , Mice , Nuclear Transfer Techniques , Parturition , Pregnancy , Stem Cells/cytology , Surrogate Mothers
14.
Biol Reprod ; 67(3): 928-34, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12193404

ABSTRACT

Successful cloning by nuclear transfer has been reported with somatic or embryonic stem (ES) cell nucleus injection into enucleated mouse metaphase II oocytes. In this study, we enucleated mouse oocytes at the germinal vesicle (GV) or pro-metaphase I (pro-MI) stage and cultured the cytoplasm to the MII stage. Nuclei from cells of the R1 ES cell line were injected into both types of cytoplasm to evaluate developmental potential of resulting embryos compared to MII cytoplasmic injection. Immunocytochemical staining revealed that a spindle started to organize 30 min after nucleus injection into all three types of cytoplasm. A well-organized bipolar spindle resembling an MII spindle was present in both pro-MI and MII cytoplasm 1 h after injection with ES cells. However, in the mature GV cytoplasm, chromosomes were distributed throughout the cytoplasm and a much bigger spindle was formed. Pseudopronucleus formation was observed in pro-MI and MII cytoplasm after activation treatment. Although no pronucleus formation was found in GV cytoplasm, chromosomes segregated into two groups in response to activation. Only 8.1% of reconstructed embryos with pro-MI cytoplasm developed to the morula stage after culture in CZB medium. In contrast, 53.5% of embryos reconstructed with MII cytoplasm developed to the morula/blastocyst stage, and 5.3% of transferred embryos developed to term. These results indicate that GV material is essential for nucleus remodeling after nuclear transfer.


Subject(s)
Cell Nucleus/ultrastructure , Nuclear Transfer Techniques , Oocytes/ultrastructure , Animals , Blastocyst , Cell Nucleus/physiology , Chromosomes/ultrastructure , Cloning, Organism , Culture Techniques , Cytoplasm/ultrastructure , DNA/ultrastructure , Embryo Transfer , Embryo, Mammalian/cytology , Embryo, Mammalian/physiology , Embryonic and Fetal Development , Female , Metaphase , Mice , Microtubules/ultrastructure , Morula , Pregnancy , Stem Cells/ultrastructure
15.
J Biol Chem ; 277(41): 38531-9, 2002 Oct 11.
Article in English | MEDLINE | ID: mdl-12122013

ABSTRACT

Telomere shortening and lack of telomerase activity have been implicated in cellular senescence in human fibroblasts. Expression of the human telomerase (hTERT) gene in sheep fibroblasts reconstitutes telomerase activity and extends their lifespan. However, telomere length is not maintained in all cell lines, even though in vitro telomerase activity is restored in all of them. Cell lines expressing higher levels of hTERT mRNA do not exhibit telomere erosion or genomic instability. By contrast, fibroblasts expressing lower levels of hTERT do exhibit telomere shortening, although the telomeres eventually stabilize at a shorter length. The shorter telomere lengths and the extent of karyotypic abnormalities are both functions of hTERT expression level. We conclude that telomerase activity is required to bypass senescence but is not sufficient to prevent telomere erosion and genomic instability at lower levels of expression.


Subject(s)
Cellular Senescence/physiology , Telomerase/genetics , Telomerase/metabolism , Telomere/metabolism , Animals , Cells, Cultured , Chromosome Aberrations , DNA-Binding Proteins , Fibroblasts , Gene Expression Regulation, Enzymologic , Humans , In Situ Hybridization, Fluorescence , Karyotyping , Time Factors
16.
Biol Reprod ; 66(3): 635-41, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11870069

ABSTRACT

Factors influencing pig oocyte activation by electrical stimulation were evaluated by their effect on the development of parthenogenetic embryos to the blastocyst stage to establish an effective activation protocol for pig nuclear transfer. This evaluation included 1) a comparison of the effect of epidermal growth factor and amino acids in maturation medium, 2) an investigation of interactions among oocyte age, applied voltage field strength, electrical pulse number, and pulse duration, and 3) a karyotype analysis of the parthenogenetic blastocysts yielded by an optimized protocol based on an in vitro system of oocyte maturation and embryo culture. In the first study, addition of amino acids in maturation medium was beneficial for the developmental competence of activated oocytes. In the second study, the developmental response of activated oocytes was dependent on interactions between oocyte age at activation and applied voltage field strength, voltage field strength and pulse number, and pulse number and duration. The formation of parthenogenetic blastocysts was optimal when activation was at 44 h of maturation using three 80-microsec consecutive pulses of 1.0 kV/cm DC. Approximately 84% of parthenogenetic blastocysts yielded by this protocol were diploid, implying a potential for further in vivo development.


Subject(s)
Electric Stimulation , Oocytes/physiology , Swine/physiology , Amino Acids/pharmacology , Animals , Blastocyst/physiology , Culture Media , Culture Techniques , Epidermal Growth Factor/pharmacology , Female , Karyotyping , Nuclear Transfer Techniques , Parthenogenesis , Time Factors
17.
Biol Reprod ; 66(3): 642-50, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11870070

ABSTRACT

To clone a pig from somatic cells, we first validated an electrical activation method for use on ovulated oocytes. We then evaluated delayed versus simultaneous activation (DA vs. SA) strategies, the use of 2 nuclear donor cells, and the use of cytoskeletal inhibitors during nuclear transfer. Using enucleated ovulated oocytes as cytoplasts for fetal fibroblast nuclei and transferring cloned embryos into a recipient within 2 h of activation, a 2-h delay between electrical fusion and activation yielded blastocysts more reliably and with a higher nuclear count than did SA. Comparable rates of development using DA were obtained following culture of embryos cloned from ovulated or in vitro-matured cytoplasts and fibroblast or cumulus nuclei. Treatment of cloned embryos with cytochalasin B (CB) postfusion and for 6 h after DA had no impact on blastocyst development as compared with CB treatment postfusion only. Inclusion of a microtubule inhibitor such as nocodozole with CB before and after DA improved nuclear retention and favored the formation of single pronuclei in experiments using a membrane dye to reliably monitor fusion. However, no improvement in blastocyst development was observed. Using fetal fibroblasts as nuclear donor cells, a live cloned piglet was produced in a pregnancy that was maintained by cotransfer of parthenogenetic embryos.


Subject(s)
Cloning, Organism , Nuclear Transfer Techniques , Oocytes/physiology , Swine , Animals , Blastocyst/physiology , Blastocyst/ultrastructure , Cytochalasin B/pharmacology , Electric Stimulation , Embryo Transfer , Female , Microtubules/drug effects , Nocodazole/pharmacology , Oocytes/ultrastructure , Parthenogenesis , Pregnancy
SELECTION OF CITATIONS
SEARCH DETAIL
...